{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.11.1274","meta":{"versionId":"6","lastUpdated":"2018-03-10T01:00:08.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2018-03-10"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1274","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.196.11.1274"}],"version":"20180310","name":"HyoscyaminePhenyltoloxamine","title":"Hyoscyamine / Phenyltoloxamine","status":"active","experimental":false,"date":"2018-03-10T01:00:08-05:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"998726","display":"Hyoscyamine Sulfate 0.0625 MG / Phenyltoloxamine citrate 15 MG Oral Capsule"}]}]},"expansion":{"identifier":"urn:uuid:e633db9c-ee61-4e5f-a1a0-422e896b3cb6","timestamp":"2023-12-11T02:31:21-05:00","total":1,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"998726","display":"hyoscyamine sulfate 0.0625 MG / phenyltoloxamine citrate 15 MG Oral Capsule"}]}}